Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases Bouguen G; Chevaux JB; Peyrin-Biroulet LWorld J Gastroenterol 2011[Feb]; 17 (5): 547-56Inflammatory bowel diseases (IBDs) are complex and chronic disabling conditions resulting from a dysregulated dialogue between intestinal microbiota and components of both the innate and adaptive immune systems. Cytokines are essential mediators between activated immune and non-immune cells, including epithelial and mesenchymal cells. They are immunomodulatory peptides released by numerous cells and these have significant effects on immune function leading to the differentiation and survival of T cells. The physiology of IBD is becoming a very attractive field of research for development of new therapeutic agents. These include cytokines involved in intestinal immune inflammation. This review will focus on mechanisms of action of cytokines involved in IBD and new therapeutic opportunities for these diseases.|Clinical Trials as Topic[MESH]|Cytokines/*immunology/*therapeutic use[MESH]|Humans[MESH]|Immune System/physiology/physiopathology[MESH]|Inflammatory Bowel Diseases/*immunology/pathology/physiopathology/*therapy[MESH]|Intestinal Mucosa/immunology/microbiology/pathology/physiopathology[MESH]|T-Lymphocytes/immunology/physiology[MESH] |
